Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease
NCT01396603 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2018-03-21
Summary
This study will evaluate a new imaging technology, termed optical frequency domain imaging (OFDI) for detecting and diagnosing pulmonary malignancy in the central airways.
Conditions
- Squamous Cell Lung Cancer
- Lung Cancer
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Melissa J Suter, PhD · Massachusetts General Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2018-01-01
- Completion
- 2018-01-01
Countries
- United States
Study Locations
More Related Trials
-
Community-Based Engagement to Improve Lung Cancer Screening and Outcomes: The "Our Lungs Our Health" Study
NCT06909981 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
NCT00733252 ·Status: WITHDRAWN
-
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy
NCT02135679 ·Status: COMPLETED
-
Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)
NCT01799135 ·Status: TERMINATED ·Phase: NA
-
Functional Lung Imaging With DECT and 4DCT
NCT04702607 ·Status: COMPLETED
-
Benefit of Spectral Information in Patients Suspected for Lung Cancer
NCT06440616 ·Status: RECRUITING ·Phase: NA
-
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers
NCT00136890 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Pulmonary Function Following Radiation Therapy
NCT02843568 ·Status: COMPLETED ·Phase: NA
-
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
NCT02117440 ·Status: TERMINATED
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer
NCT01799395 ·Status: TERMINATED
-
Phase 2 Study of VGT-309 in Lung Cancer
NCT05400226 ·Status: COMPLETED ·Phase: PHASE2
-
Intraoperative Imaging of Pulmonary Nodules by OTL38
NCT02602119 ·Status: COMPLETED ·Phase: PHASE1
-
Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer
NCT00089310 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer
NCT03679936 ·Status: UNKNOWN
-
Chest Imaging, Breath, and Biomarkers in a Screening Trial
NCT01663155 ·Status: COMPLETED
-
CT-guided Radioactive I-125 Seeds Implantation for Early Stage Lung Cancer
NCT03916367 ·Status: COMPLETED
-
Circulating Tumor Cells in Lung Cancer Screening
NCT02500693 ·Status: COMPLETED ·Phase: NA
-
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
NCT06016569 ·Status: RECRUITING ·Phase: NA
-
Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With Radiotherapy
NCT06557343 ·Status: RECRUITING
-
Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
NCT00914147 ·Status: COMPLETED ·Phase: NA
-
Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
NCT01039311 ·Status: TERMINATED
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
Breath Analysis to Diagnose Lung Cancer
NCT03250390 ·Status: COMPLETED ·Phase: NA